In TCGA, high SLC2A1 expression was associated with decreased tumor-infiltrating lymphocytes (TILs), CD8 T cells, B cells, T cell receptor (TCR) expression and B cell receptor (BCR) expression (p = 0.001, 0.004, 0.009, 0.001 and 0.009, respectively) (Fig 3C), while its expression was associated with increased proliferation and cancer/testis antigen (CTA) expression (p = 0.001 and 0.009, respectively) (Fig 3D). The gene discussed is SLC2A1; the disease is neoplasm.